PharmaShots | Incisive News in 3 Shots

Subscribe Now

Five Indications

Celltrion's Remsima SC (infliximab- CT-P13) Receives the EC's MAA for Additional Five Indications

Celltrion's Remsima SC (infliximab- CT-P13) Receives the EC's MAA for Additional Five Indications

July 27, 2020

Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Inflammatory Bowel Disease and Ankylosing Spondylitis

Celltrion's Remsima SC (biosimilar- infliximab) Receives CHMP's Positive Opinion for an Additional Five Indications Including Infl...

June 30, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us